Biopharmaceutical lifecycle management platform IDBS (Guildford, UK) has announced a strategic partnership with software provider Scitara (MA, USA) to provide a combined laboratory data connectivity and instrument integration solution.
Workflows provided by IDBS’ Polar biopharmaceutical lifecycle management platform will be powered by Scitara Digital Laboratory Exchange, improving efficiency by removing manual processes and enabling high-quality, contextualized data, which will support laboratory decision-making. Solutions provided will include out-of-the-box instrument integration, equipment, informatics systems and enterprise platforms.
CEO of Scitara, Ajit Nagral, stated:
“Universal access to laboratory data is crucial to the success of science-based industry’s digital transformation journey…The Scitara Digital Laboratory Exchange (DLX) platform provides seamless peer-to-peer data connectivity for all laboratory instruments and applications, enables simple yet comprehensive data transformation and workflow automation, and creates a trusted digital trail of all lab data transactions for further analysis and decision-making. Our partnership with IDBS will enable their [biopharmaceutical lifecycle management] solution to interoperate with hundreds of systems connected to our laboratory data exchange backbone. We are excited to bring these capabilities to the IDBS user community and look forward to regulated and nonregulated customers reaping the benefits of our joint solution.”
Pietro Forgione, Vice President, Strategy at IDBS, commented:
“Scitara DLX will power the IDBS Polar platform by delivering best-in-class integration capabilities that uphold the highest standards of data integrity and remove roadblocks in capturing, contextualizing and gaining insights from data. By integrating with the IDBS cloud, Scitara DLX will also extend these capabilities to the broader IDBS cloud customer base.”
Source: IDBS press release https://www.idbs.com/2021/02/idbs-and-scitara-announce-strategic-partnership-dlx-and-polar/
The post Strategic partnership announced between IDBS and Scitara appeared first on Bioanalysis Zone.
more recommended stories
The Fight for Air Climb and Other Extraordinary Feats by People With PF
A couple of weeks ago, Bert.
Inflatable Neurostimulator for Minimally Invasive Pain Control
Researchers at the University of Cambridge.
Glucagon-like Peptide-1 Metabolism is Impacted by Anthocyanins and (-)-epicatechin
Obesity and diabetes are major health.
The Last Mile: Overcoming COVID-19 Vaccine Hesitancy
Special thanks to Marc Benjamin, a.
The latest science on staying healthy during pregnancy
New research examines prenatal supplements, how.
Relapsed, Refractory Follicular Lymphoma: CAR-T Cell Therapy Shows Promise
Axicabtagene ciloleucel (axi-cel) appears to be.
Living With PTSD? How to Manage Anxiety and Flashbacks
If you have post-traumatic stress disorder (PTSD), you.
DLBCL: Naratuximab Shows Promise Among Patients With Relapsed/Refractory Disease
Among patients with diffuse large B.
Quasiprobabilities Shed Light on Quantum Advantage
Quantum advantage is a hot topic,.
Antibody Response to 1 Dose SARS-CoV-2 mRNA Vaccine in Previously Infected HCWs
Antibody titer responses to a single.